311 related articles for article (PubMed ID: 31696485)
1. LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma.
Zhang N; Liu FL; Ma TS; Zhang ZZJ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8971-8983. PubMed ID: 31696485
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma.
Qu A; Yang Q
Neoplasma; 2020 May; 67(3):557-566. PubMed ID: 32122143
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
5. CircKIF2A contributes to cell proliferation, migration, invasion and glycolysis in human neuroblastoma by regulating miR-129-5p/PLK4 axis.
Yang Y; Pan H; Chen J; Zhang Z; Liang M; Feng X
Mol Cell Biochem; 2021 Jun; 476(6):2513-2525. PubMed ID: 33630225
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
7. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
Bao J; Zhang S; Meng Q; Qin T
Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621
[TBL] [Abstract][Full Text] [Related]
8. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
Jia P; Wei E; Liu H; Wu T; Wang H
IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637
[TBL] [Abstract][Full Text] [Related]
9. LINC00839 Promotes Neuroblastoma Progression by Sponging miR-454-3p to Up-Regulate NEUROD1.
Zhang Q; Wei J; Li N; Liu B
Neurochem Res; 2022 Aug; 47(8):2278-2293. PubMed ID: 35606572
[TBL] [Abstract][Full Text] [Related]
10. SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells.
Xu Z; Sun Y; Wang D; Sun H; Liu X
Cancer Cell Int; 2020; 20():236. PubMed ID: 32536824
[TBL] [Abstract][Full Text] [Related]
11. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
Li C; Gao Q; Wang M; Xin H
J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell.
Lan X; Liu X
J Cell Mol Med; 2019 Apr; 23(4):2351-2361. PubMed ID: 29575772
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis.
Liu ZQ; He WF; Wu YJ; Zhao SL; Wang L; Ouyang YY; Tang SY
BMC Gastroenterol; 2020 May; 20(1):156. PubMed ID: 32423385
[TBL] [Abstract][Full Text] [Related]
16. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
Tian P; Wei JX; Li J; Ren JK; Yang JJ
Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
[TBL] [Abstract][Full Text] [Related]
19. LncRNA double homeobox A pseudogene 8 (DUXAP8) facilitates the progression of neuroblastoma and activates Wnt/β-catenin pathway via microRNA-29/nucleolar protein 4 like (NOL4L) axis.
Nie L; Li C; Zhao T; Wang Y; Liu J
Brain Res; 2020 Nov; 1746():146947. PubMed ID: 32522628
[TBL] [Abstract][Full Text] [Related]
20. Lnc-SNHG1 Activates the TGFBR2/SMAD3 and RAB11A/Wnt/β-Catenin Pathway by Sponging MiR-302/372/373/520 in Invasive Pituitary Tumors.
Wang H; Wang G; Gao Y; Zhao C; Li X; Zhang F; Jiang C; Wu B
Cell Physiol Biochem; 2018; 48(3):1291-1303. PubMed ID: 30048990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]